tallózása szerző szerint "Varadi Z"

1-2 / 2

Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease - a combined tissue microarray, in vitro and in vivo study.

Márk, Ágnes; Hajdu, Melinda; Varadi Z; Sticz TB; Nagy, Noémi; Csomor, Judit; Berczi L; Varga V; Csóka, Monika; Kopper, László; Sebestyén, Anna (2013)

BACKGROUND: Targeting signaling pathways is an attractive approach in many malignancies. The PI3K/Akt/mTOR pathway is activated in a number of human neoplasms, accompanied by lower overall and/or disease free survival. ...
Gyermekkori lágyrészsarcomak diagnosztikája es kezelése.

Bánusz, Rita; Varadi Z; Varga, Edit; Jakab, Zsuzsanna; Garami, Miklós; Csóka, Monika (2014)

Malignant tumors of mesenchymal origin are called sarcomas. Mesenchymal cells normally mature into skeletal muscle, smooth muscle, fat, fibrous tissue, bone and cartilage. Rhabdomyosarcoma (RMS) arises from immature ...

1-2 / 2

Keresés